Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-kB-inducing kinase-specific siRNA using liver-targeting liposomes
Archives of Pharmacal Research, 08/07/09
Cho HA et al. – These liposomes assisted the delivery of the siRNA to specific cells and protected it from various lyases, followed by the ultimate suppression of HCC.
Related Articles
Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis
Annals of Surgical Oncology, 11/11/09
Relevance Score: 69%
Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease
American Journal of Roentgenology, 10/09/09
Relevance Score: 69%
Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma
World Journal of Gastroenterology, 10/27/09
Relevance Score: 68%
Cryotherapy for hepatocellular carcinoma
Cochrane Reviews, 10/09/09
Relevance Score: 68%
MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09
Relevance Score: 68%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
International Journal of Clinical Oncology, 12/15/09
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
GlaxoSmithKline, 12/15/09
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Woman Previously Treated with Chemotherapy for Advanced Breast Cancer
Genentech, 12/15/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer
The Journal of Thoracic and Cardiovascular Surgery, 12/14/09
Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


